SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,390,000 | -53.8% | 696,785 | -4.2% | 0.00% | -33.3% |
| Q1 2022 | $5,178,000 | -20.9% | 727,258 | -7.4% | 0.00% | -25.0% |
| Q4 2021 | $6,543,000 | +7.5% | 785,519 | -10.2% | 0.00% | 0.0% |
| Q3 2021 | $6,089,000 | -95.2% | 874,923 | -83.5% | 0.00% | -94.7% |
| Q2 2021 | $126,166,000 | +3.0% | 5,289,965 | -11.1% | 0.08% | -2.6% |
| Q1 2021 | $122,513,000 | -14.1% | 5,950,118 | +2.2% | 0.08% | -16.3% |
| Q4 2020 | $142,678,000 | -8.9% | 5,823,603 | +5.3% | 0.09% | -12.4% |
| Q3 2020 | $156,602,000 | +344.6% | 5,531,670 | -25.3% | 0.10% | +320.0% |
| Q2 2020 | $35,225,000 | +17.2% | 7,400,245 | -12.1% | 0.02% | -3.8% |
| Q1 2020 | $30,053,000 | +5.3% | 8,418,320 | +1.8% | 0.03% | +18.2% |
| Q4 2019 | $28,543,000 | -7.1% | 8,273,223 | +8.0% | 0.02% | -18.5% |
| Q3 2019 | $30,724,000 | +97.0% | 7,661,963 | +58.2% | 0.03% | +92.9% |
| Q2 2019 | $15,595,000 | +183.3% | 4,843,074 | +504.5% | 0.01% | +180.0% |
| Q1 2019 | $5,504,000 | – | 801,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |